iShares Biotechnology ETF
IBB
IBB
317 hedge funds and large institutions have $5.3B invested in iShares Biotechnology ETF in 2014 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 96 increasing their positions, 117 reducing their positions, and 31 closing their positions.
Holders
317
Holders Change
+11
Holders Change %
+3.59%
% of All Funds
9.2%
Holding in Top 10
17
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+21.43%
% of All Funds
0.49%
New
43
Increased
96
Reduced
117
Closed
31
Calls
$461M
Puts
$594M
Net Calls
-$134M
Net Calls Change
+$103M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$342M |
| 2 |
2
Goldman Sachs
New York
|
$1.05B |
| 3 |
3
Citigroup
New York
|
$583M |
| 4 |
4
Morgan Stanley
New York
|
$641M |
| 5 |
U
5
UBS
Zurich,
Switzerland
|
$335M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GF
351
Gerry Farber
New York
| – | – | – | – |
|
|
ACPU
352
Arrowgrass Capital Partners (US)
Dover,
Delaware
| – | – | – | – |
|
|
O
353
OrbiMed
New York
| – | – | – | – |
|
|
CI
354
Cowen Inc
New York
| – | – | – | – |
|
|
NCM
355
Nantahala Capital Management
New Canaan,
Connecticut
| – | – | – | – |
|
|
KCM
356
Kingdon Capital Management
New York
| – | – | – | – |
|
|
SFM
357
Soros Fund Management
New York
| – | – | – | – |
|
|
CA
358
Continental Advisors
Park City,
Utah
| – | – | – | – |
|
359
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $0 | 100 | – | – |
|
|
NRCM
360
Northern Right Capital Management
Darien,
Connecticut
| – | – | – | – |
|
361
Capstone Investment Advisors
New York
| – | – | – | – |
|
|
IPC
362
Independent Portfolio Consultants
Boca Raton,
Florida
| – | – | – | – |
|
|
ACH
363
ArrowMark Colorado Holdings
Denver,
Colorado
| – | – | – | – |
|
|
PCM
364
Potomac Capital Management
New York
| – | – | – | – |
|